<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04571177</url>
  </required_header>
  <id_info>
    <org_study_id>Version 1.0 28AUG2019</org_study_id>
    <nct_id>NCT04571177</nct_id>
  </id_info>
  <brief_title>PET Perfusion Imaging Techniques and Comparing Them to CT Perfusion Imaging in Stroke</brief_title>
  <official_title>Developing PET Perfusion Imaging Techniques and Comparing Them to CT Perfusion Imaging in Stroke Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Alberta</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Alberta</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Adult patients who are diagnosed with an acute supratentorial ischemic stroke within 48 hrs&#xD;
      of onset will be enrolled into the study. Participants will undergo both a CT Scan and PET&#xD;
      scan within 7 days of onset. Participants will have the option to undergo a second PET scan&#xD;
      with fluorodeoxyglucose (FDG).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients older than 18 years of age diagnosed with an acute supratentorial ischemic stroke&#xD;
      within 48 hrs of symptom onset will be prospectively enrolled. Research imaging will be&#xD;
      obtained before 7 days after symptom onset. The patient will receive the standardized&#xD;
      treatment protocol at the hospital. Informed consent will be obtained from each patient or a&#xD;
      substitute decision maker for each individual imaging study (CTP, Rb PET, and FDG PET). The&#xD;
      patient will be given the option of undergoing the CTP imaging with the Rb PET only or both&#xD;
      the Rb PET and FDG PET components.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 1, 2022</start_date>
  <completion_date type="Anticipated">December 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Compare PET brain perfusion imaging to CTP</measure>
    <time_frame>through study completion, 1 year from start of recruitment</time_frame>
    <description>Imaging of CTP images with the Rb PET only or both the Rb PET and FDG PET with CTP imaging components to evaluate blood flow and metabolism mismatches.</description>
  </primary_outcome>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Acute Ischemic Stroke</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who are older than 18 years of age diagnosed with an acute supratentorial ischemic&#xD;
        stroke within 48 hrs of onset will be enrolled into the study. Both male and female&#xD;
        patients will be enrolled. We want diversity among participants in order to gain insightful&#xD;
        information about acute supratentorial ischemic stroke as possible. A broad range in age,&#xD;
        along with enrolling both male and female participants will allow greater diversity.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age: &gt;18 yo&#xD;
&#xD;
          -  Gender: male or female&#xD;
&#xD;
          -  Acute (within 7 days from symptom onset) Supratentorial Ischemic Stroke&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  1) Planned surgical intervention&#xD;
&#xD;
          -  2) Severely abnormal blood glucose level (will be excluded from FDG PET imaging)&#xD;
&#xD;
          -  3) Unable to undergo CTP or PET imaging (i.e. claustrophobia)&#xD;
&#xD;
          -  4) Pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Brian Buck</last_name>
    <role>Principal Investigator</role>
    <affiliation>Associate Professor</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Brian Buck</last_name>
    <phone>780-248-1927</phone>
    <email>bbuck@ualberta.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Paige Fairall</last_name>
    <phone>780-248-1118</phone>
    <email>fairall@ualberta.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Alberta</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <zip>T6G2B7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>May 19, 2020</study_first_submitted>
  <study_first_submitted_qc>September 25, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 30, 2020</study_first_posted>
  <last_update_submitted>November 10, 2020</last_update_submitted>
  <last_update_submitted_qc>November 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 12, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Ischemic Stroke</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

